Morbidity of interventions in previously untreated Dupuytren disease: A systematic review
Treatment morbidity in previously untreated, or primary, Dupuytren disease has limited representation in the literature. Despite the clinical importance of stratifying risk of intervention based on treatment history, most articles addressing management complications pool both primary and recurrent disease. The aim of this systematic review was to quantify interventional morbidity in primary Dupuytren disease only and isolate the complication profiles of established interventions in previously untreated patients. A literature search was conducted using keywords on Medline and bibliographic linkage. Excluded papers did not address primary Dupuytren disease complications or did not include separate, primary-only complication data. Rates of morbidity were calculated from pooled data extracted from the included studies. Thirty-five papers met the criteria for inclusion. The review has quantified that open procedures carry higher complication rates than closed in the context of primary Dupuytren disease treatment. Amongst closed procedures, the only rate of skin split was high. It is noteworthy that this review has identified the limited isolated primary disease complication data available in the literature, which should prompt further targeted research. This systematic review addresses quantification of complication rates following treatment of primary Dupuytren disease and demonstrates that open interventions carry greater morbidity than closed. Whilst this study highlights the need for a future investigation, the complication data presented should nonetheless facilitate informed decision-making for clinicians and patients when considering initial treatments for primary Dupuytren disease.
Level of Evidence: Level IV, therapeutic study.
KeywordsDupuytren’s contracture Complication Fasciotomy Collagenase Fasciectomy Dermofasciectomy
Compliance with ethical standards
The authors received no financial support for the research, authorship and/or publication of this article.
This article does not contain any studies with human participants or animals performed by any of the authors.
Conflict of interest
Rachael Leung, Robert Capstick, Angela Lei, David Nour, Warren Rozen and David Hunter-Smith declare that they have no conflict of interest.
- 18.Mavrogenis AF, Spyridonos SG, Ignatiadis IA, Antonopoulos D, Papagelopoulos PJ (2009) Partial fasciectomy for Dupuytren’s contractures. J Surg Orthop Adv 18(2):106–110Google Scholar
- 22.Kan HJ, Selles RW, van Nieuwenhoven CA, Zhou C, Khouri RK, Hovius SE (2016) Percutaneous aponeurotomy and lipofilling (PALF) versus limited fasciectomy in patients with primary Dupuytren’s contracture: a prospective, randomized, controlled trial. Plast Reconstr Surg 137(6):1800–1812CrossRefGoogle Scholar
- 26.Stahl S, Calif E (2008) Dupuytren’s palmar contracture in women. Isr Med Assoc J 10(6):445–447Google Scholar
- 27.Tate R, Mackay D, Broome G (2011) A prospective study of limited palmar and digital fasciectomy under local anaesthetic wrist block and upper arm tourniquet. J Hand Surg Eur 36 (9):811–812. doi:Google Scholar
- 28.Pereira A, Massada M, Sousa R, Silva C, Trigueiros M, Lemos R (2012) Percutaneous needle fasciotomy in Dupuytren’s contracture: is it a viable technique? Acta Orthop Belg 78(1):30–34Google Scholar
- 30.Denkler K (2010) Surgical complications associated with fasciectomy for Dupuytren’s disease: a 20-year review of the English literature. Eplasty 10:e15Google Scholar
- 34.Grandizio LC, Akoon A, Heimbach J, Graham J, Klena JC (2017) The use of residual collagenase for single digits with multiple-joint Dupuytren contractures. J Hand Surg Am 2017:04Google Scholar
- 37.Peimer CA, Blazar P, Coleman S, Kaplan FT, Smith T, Lindau T (2015) Dupuytren contracture recurrence following treatment with collagenase Clostridium histolyticum (CORDLESS [collagenase option for reduction of Dupuytren long-term evaluation of safety study]): 5-year data. J Hand Surg Am 40(8):1597–1605CrossRefGoogle Scholar
- 40.Paynter J, Tobin V, Rozen W, Hunter-Smith D (2018) Dupuytren’s disease and collagenase: evidence for a paradigm shift in management. Aust J Plast Surg 1(2)Google Scholar